Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. MediPal Holdings Corporation
  6. News
  7. Summary
    7459   JP3268950007

MEDIPAL HOLDINGS CORPORATION

(7459)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Nichi-Iko Pharmaceutical Co., Ltd. announced that it expects to receive ¥5.23102 billion in funding from MediPal Holdings Corporation

08/17/2021 EST

Nichi-Iko Pharmaceutical Co., Ltd. announced a private placement of 6,22,000 common shares at the price of ¥841 per share for gross proceeds of ¥5,231,020,000 on August 17, 2021. The transaction will include participation from MediPal Holdings Corporation. The company will issue shares through third party allocation method. The company will incur ¥40,000,000 as issuance expenses with respect to the transaction including attorney's fees and other administrative costs (securities registration statement preparation costs, payment handling bank fees, change registration costs, etc.). The transaction has been approved by board of directors of the company. The payment date for the transaction is September 2, 2021. Post the closing, MediPal Holdings Corporation will own 9.90% stake of the company.


© S&P Capital IQ 2021
All news about MEDIPAL HOLDINGS CORPORATION
09/29MEDIPAL HOLDINGS CORPORATION : Ex-dividend day for interim dividend
FA
09/02Nichi-Iko Pharmaceutical Co., Ltd. announced that it has received ¥5.23102 billion in f..
CI
08/17Nichi-Iko Pharmaceutical Co., Ltd. announced that it expects to receive ¥5.23102 billio..
CI
08/10Orizuru Therapeutics Inc. announced that it has received funding from Kyoto University ..
CI
06/11Heartseed Inc. announced that it has received ¥4 billion in funding from a group of inv..
CI
03/30MEDIPAL HOLDINGS CORPORATION : Ex-dividend day for final dividend
FA
02/16CARADA medica Inc. announced that it expects to receive ¥6.157 billion in funding from ..
CI
2020MEDIPAL HOLDINGS CORPORATION : Ex-dividend day for interim dividend
FA
2020CRYOPORT : MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controlled Supply ..
AQ
2020MediPal Holdings Corporation Partners with Cryoport, Inc. to Bring Temperature-Controll..
CI
More news
Financials
Sales 2022 3 288 B 29 000 M 29 000 M
Net income 2022 31 900 M 281 M 281 M
Net Debt 2022 - - -
P/E ratio 2022 13,4x
Yield 2022 2,15%
Capitalization 417 B 3 675 M 3 674 M
Capi. / Sales 2022 0,13x
Capi. / Sales 2023 0,13x
Nbr of Employees 12 971
Free-Float 75,5%
Chart MEDIPAL HOLDINGS CORPORATION
Duration : Period :
MediPal Holdings Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIPAL HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 1 984,00 JPY
Average target price 2 183,33 JPY
Spread / Average Target 10,0%
EPS Revisions
Managers and Directors
Shuichi Watanabe President & Representative Director
Takeshi Yanagida Senior Manager-Compliance
Yuji Sakon Managing Director & General Manager-Administration
Mitsuko Kagami Independent Outside Director
Kuniko Shoji Independent Director
Sector and Competitors